Thus, our findings together with the observation of increased hepatic Pparγ2 expression in obese models and NAFLD provide evidence that insulin is sufficient to induce, but is not required for maintenance of, Pparγ2 expression. Here, PPARG is linked to metabolic dysfunction-associated steatotic liver disease.